Sangeeta Singg, PhD, LP, ACN
Journal of Clinical Trials, Pathology and Case Studies Journal of Clinical Trials, Pathology and Case Studies is a leading international journal covering all aspects. Journal of Clinical Trials, Pathology and Case Studies (CPCS) is a broad-based journal that aims to publish the most exciting Case studies in Clinical and Medical Sciences catering to the requirements of research, teaching and reference aspects. (CPCS) keeps updating day-to-day research & development to the scientific niche around the world. The journal publishes case studies or case report, commentary, editorials, letters to the editor, describing original contents in the fields of medical and life sciences Diagnostic and research areas covered include histopathology, virology, haematology, microbiology, cytopathology, chemical pathology, molecular pathology, forensic pathology ,symptoms, signs, diagnosis, therapeutic techniques and solutions of individuals, a small group of participants.
Aim & Scope
AIMS AND SCOPE: It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals, researchers professional bodies and institutions. All works published by OMMEGA Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. (CPCS) strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. (CPCS) keeps updated information on the latest advances in the field Clinical research and Case reports. Abstracts and full texts (HTML, PDF and XML format) of all articles published by (CPCS) are freely accessible to everyone immediately after publication. Many believe that informed consent makes Clinical Trials, Pathology and Case Studies ethical. However, informed consent is not sufficient. Drawing on the basic philosophies there are some requirements that systematically explain a logical framework for evaluating the ethics of clinical research studies. The requirements are universal and they must be adapted to the various fields in which research is conducted.
EDITORIAL MANAGING SYSTEM Ommega Publications supports scientist who sweats for the real innovation & discovery in the field of science, technology and medicine. Our online Editorial Managing System (EMS) provides quality and quick editorial process towards rapid publication, so that the author can support the scientific community with wide scientific information. Advanced automated Editorial Managing System simplifies the publication process and helps the author to get track of their articles. The IJCCS is Open Access publication to maintain a common relation among the common public and researcher by providing wide scientific information.
Drug discovery Emerging drugs
Drug design Clinical research
Drug clinical trials
Automated Tissue Image
Analysis Cellular Pathology
Cooperative Human Tissue Network
Ommega Publishers sincerely believes and charges reasonably in other words it is one of the publishers that provides a platform which charges economically towards the publication charges so that there are no barriers for free and fruitful knowledge sharing. Ommega Publishers have also classified their charges as defined by the World Bank Country Classification table: High Income countries, Middle Income countries and Low Income countries
Ommega journals are Open Access and do not receive any funding, we solely depend on Authors through membership fees, and article processing charges to meet the expenses like managing the team of Editorial experts and professionals to advance and support needs arising in the fields of editorials boards,marketing and IT, peer reviewing of the articles,editing of articles, developing and maintaining the software and information technology, updating the journal website, archiving of the articles and other costs associated concerning to maintain global standards of Publishing.
Ommega publishers believes and maintains high quality of services and articles through this model each and every manuscript that is accepted attract publication charges.Ommega publishers does not support any hidden costs, charge for color figures,as well as does not charge any additional fees for all the authors worldwide.
If for some reason, Researcher/ Author is unable to pay the processing charges, they can submit their applications citing the reasons for a waiver or discount to firstname.lastname@example.org before or immediately after submitting their article.
Waivers are calculated on the Article processing fees of the related Journal after the submission and acceptance of the manuscript.
"Article Publishing Charges"charged by Ommega Online Publishers for publishing manuscripts are as follows.
CR= Case report
RA = Review Article/ Research Article
Note:The prices and guidelines mentioned above are subject to change without prior notice.
Clinical trials, Diabetic trials, Drug action, Drug delivery, Drug discovery, Emerging drugs, Drug design, Clinical research, Drug clinical trials, Vaccine trials, Prevention trials, Screening trials, Diagnostic trials, Treatment trials